Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients

NCT02490488 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Masitinib
DRUG: Gemcitabine
DRUG: Placebo

Sponsor

AB Science